Gain-of-function mutations in the type I receptor ALK2 cause fibrodysplasia ossificans progressiva (FOP) and diffuse intrinsic pontine glioma (DIPG)17. The gene discussed is ACVR1; the disease is diffuse intrinsic pontine glioma.